Cleocin Phosphate Injection, Solution
NDC Package 0009-0775-26
Package Information
Cleocin Phosphate (clindamycin phosphate) injection is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a injection, solution delivery system. Marketed by Pharmacia & Upjohn Company Llc, this product is identified by NDC 0009-0775 and is authorized under FDA application NDA050441.
Identification & Billing
- RxCUI: 1737244 - clindamycin 300 MG in 2 ML Injection
- RxCUI: 1737244 - 2 ML clindamycin 150 MG/ML Injection
- RxCUI: 1737244 - clindamycin (as clindamycin phosphate) 300 MG per 2 ML Injection
- RxCUI: 1737244 - clindamycin 300 MG per 2 ML Injection
- RxCUI: 1737245 - Cleocin Phosphate 300 MG in 2 ML Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 0009 - Pharmacia & Upjohn Company Llc
- 0009-0775 - Cleocin Phosphate
- 0009-0775-26 - 25 VIAL in 1 CARTON / 4 mL in 1 VIAL (0009-0775-20)
- 0009-0775 - Cleocin Phosphate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0009-0775-26 identifies a specific commercial package of 25 vial in 1 carton / 4 ml in 1 vial (0009-0775-20) of Cleocin Phosphate, a human prescription drug labeled by Pharmacia & Upjohn Company Llc. This injection, solution is formulated for intramuscular; intravenous use and contains clindamycin phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pharmacia & Upjohn Company Llc on October 02, 1972. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used to treat meningitis.
How is this Pharmacia & Upjohn Company Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00009077526. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
